Impact Factor
3.10
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.94
764 total citations
h5-index
24
h5 depth signal
Cited share
57.2%
235 of 411
Total citations
764
Citation footprint
Metric signal
1.94
External metric anchor
Self-citation
7.7%
59 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
1,063
United States
119
United Kingdom
52
Iran
28
China
27
Citing Fields of Research
Digestive Disorders
626
Liver Diseases
372
Hepatitis
185
Inflammatory Bowel Diseases & Infections
170
Abdominal Surgery
94
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,110
Articles tracked across the journal lifetime
Indexed publication set
411
235 cited publications
Last 12 months
190
15.8 publications/month
Open access share
7.4%
14 OA publications in the last year
Leading citing country
India
1,063 citing publications
Leading citing field
Digestive Disorders
626 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1982-
v1n1, 1982-
Active Coverage
Research Focus & Classification
Indexed Subjects
Digestive Disorders
Liver Diseases
Inflammatory Bowel Diseases & Infections
Hepatitis
Issuing & Sponsoring Bodies
Contributor
Indian Society of Gastroenterology
Broad Categories
Gastroenterology
Digestive Disorders
Liver Diseases
Inflammatory Bowel Diseases & Infections
MeSH Descriptors
Gastroenterology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s12664-026-02040-1
Open DOI
Outcomes of Clostridium difficile infection in liver transplant patients: A systematic review and meta-analysis
Background: Clostridioides difficile infection (CDI) is a significant healthcare-associated complication, especially for liver transplant (LT) recipients who are at increased risk due to their immuno-suppressed status and antibiotic use....
02
03
04
05
DOI 10.1007/s12664-026-02088-z
Open DOI
Conservative management of groove pancreatitis: Defining success while preserving diagnostic vigilance
06
DOI 10.1007/s12664-026-02092-3
Open DOI
Mastic gum as an adjunct to bismuth quadruple therapy for Helicobacter pylori eradication
07
DOI 10.1007/s12664-026-02049-6
Open DOI
Bowel habits and functional bowel disorders in Sri Lankan adults: A cross-sectional study
Background Definitions of normal bowel habits vary across populations and are influenced by diet, lifestyle and cultural factors. Sri Lanka lacks population-level data describing normative bowel habits and the prevalence of functional bo...
08
DOI 10.1007/s12664-026-02048-7
Open DOI
Trends in the use of biologic agents and their persistence rates in inflammatory bowel disease in India
Background Biologic agents revolutionized the treatment of inflammatory bowel disease (IBD), yet their usage rates in India have historically been among the lowest globally. This is primarily attributed to cost. Data is scarce regarding ...
09
10
DOI 10.1007/s12664-026-02044-x
Open DOI
What is new in Rome V?: Redefining diagnostic criteria and clinical pathways in disorders of gut-brain interaction
Bibliographical & Catalog Notes
Description based on: Vol. 2, no. 1 (Apr. 1983); title from cover.
Print issues ceased with v. 29 (2010)
Vol. 1 complete in one issue; v. 2 complete in three issues.
Also issued online.